 Use inhaled corticosteroids patients mild asthma double blind parallel group study effect inhaled budesonide moderate micrograms low micrograms daily dosage effect placebo adults mild symptomatic asthma Subjects peak expiratory flow PEF symptoms agonist consumption home period weeks week weeks treatment baseline PEF normal micrograms budesonide micrograms placebo PEF normal active placebo treatment comparison placebo significant decrease nocturnal asthma symptoms agonist consumption changes day pronounced significant micrograms budesonide significant differences active treatments low doses inhaled budesonide effective patients mild symptomatic asthma night time symptoms early morning lung function early introduction inhaled corticosteroids patients mild asthma night time symptoms quality life night early morning